[1] Matsubara K, Yanagida K, Nagai T,et al. De Novo small supernumerary marker chromosomes arising from partial trisomy rescue[J]. Front Genet, 2020, 11: 132. [2] McGowan-Jordan J, Hastings RJ, Moore S, et al. ISCN 2020: An international system for human cytogenomic nomenclature (2020)[M].Karger, Basel, Switzerland: 2020. [3] Guzewicz L, Howell S, Crerand CE, et al. Clinical phenotype and management of individuals with mosaic monosomy X with Y chromosome material stratified by genital phenotype[J]. Am J Med Genet A, 2021, 185(5):1437-1447. [4] Li T, Sang H, Chu G, et al. Genotype-phenotype correlation in 75 patients with small super -numerary marker chromosomes[J]. Mol Cytogenet, 2020, 13: 30. [5] Vogt PH, Besikoglu B, Bettendorf M, et al. Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY[J]. Hum Reprod, 2019, 34(4):770-779. [6] Knauer-Fischer S, Besikoglu B, Inta I, et al. Analyses of Gonadoblastoma Y(GBY) -locus and of Y centromere in Turner syndrome patients[J]. Exp Clin Endocrinol Diabetes, 2015, 123: 61-65. [7] 郭苗, 陈洁, 罗敏, 等. Turner综合征中额外小标记染色体的临床意义探索[J]. 生殖医学杂志, 2021, 30(3):297-303. Guo M, Chen J, Luo M, et al. Clinical significance of small supernumerary marker chromosome in Turner syndrome[J]. J Reprod Med, 2021, 30(3):297-303.(in Chinese) [8] Debo B, Van Loocke M, De Groote K, et al. Multidisciplinary approach to the child with sex chromosomal mosaicism including a Y-containing cell line[J]. Int J Environ Res Public Health, 2021, 18(3):917. [9] Chen J, Guo M, Luo M, et al. Clinical characteristics and management of Turner patients with a small supernumerary marker chromosome[J]. Gynecol Endocrinol, 2021, 37(8):730-734. [10] Monteiro B, Arenas M, Prata MJ, et al. Evolutionary dynamics of the human pseudoautosomal regions[J]. PLoS Genet, 2021, 17(4):e1009532. [11] Castro A, Rodríguez F, Flórez M, et al. Pseudoautosomal abnormalities in terminal AZFb+c deletions are associated with isochromosomes Yp and may lead to abnormal growth and neuropsychiatric function[J]. Hum Reprod, 2017, 32(2):465-475. [12] Angkasekwinai P, Dong C. IL-9-producing T cells: Potential players in allergy and cancer[J]. Nat Rev Immunol, 2021, 21(1):37-48. [13] Kiran Z, Jamil T. Primary amenorrhoea secondary to two different syndromes:A case study[J]. BMJ Case Rep. 2019,12(3):e228148. [14] 中华医学会儿科学分会内分泌遗传代谢学组. 性发育异常的儿科内分泌诊断与治疗共识[J].中华儿科杂志, 2019, 59(6):410-418. The Subspecialty Group of Endocrinologic, Hereditary and Metabolic Diseases, The Society of Pediatrics, Chinese Medical Association. Consensus statement on the diagnosis and endocrine treatment of children with disorder of sex development[J]. Chin J Pediatr, 2019, 59(6):410-418.(in Chinese) [15] 吴琼, 周裕林, 孔辉, 等.用荧光原位杂交技术鉴定标记染色体的来源[J]. 中华医学遗传学杂志, 2013, 30(4):415-419. WU Q, Zhou YL, Kong H, et al.Identification of origins of marker chromosomes using fluorescence in situ hybridization[J]. Chin J Med Genetics, 2013, 30(4):415-419.(in Chinese) [16] Wang H, Wang T, Yang N, et al. The clinical analysis of small supernumerary marker chromosomes in 17 children with mos 45,X/46,X,+mar karyotype[J].Oncol Lett. 2017, 13(6):4385-4389. [17] Liehr T, Williams HE, Ziegler M, et al. Small supernumerary marker chromosomes derived from chromosome 14 and/or 22[J]. Mol Cytogenet, 2021, 14(1):13. [18] Liehr T, Al-Rikabi A. Mosaicism: Reason for normal phenotypes in carriers of small supernumerary marker chromosomes with known adverse outcome. A systematic review[J]. Front Genet, 2019, 10: 1131. |